Avasimibe downregulated the levels of the proteins CDK2, CDK4, CDK6, Cyclin D1, and Cyclin A1 + A2 and upregulated the levels of E2F-1 and p21 in PCa cells [41, 42]. The gene discussed is CCND1; the disease is posterior cortical atrophy.